Mba Advisors LLC Abb Vie Inc. Transaction History

Mba Advisors LLC

$195 Million
Q2 2024

A detailed history of Mba Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mba Advisors LLC holds 6,218 shares of ABBV stock, worth $1.21 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

6,218

Previous 5,723 8.65%

Holding current value

$1.21 Million

Previous $1.04 Million 2.3%

% of portfolio

0.55%

Previous 0.54%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $76,621 - $89,476	495 Added 8.65%	6,218 $1.07 Million
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $67,603 - $77,028	-423 Reduced 6.88%	5,723 $1.04 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $18,576 - $20,920	-135 Reduced 2.15%	6,146 $952,000
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $2,538 - $2,938	19 Added 0.3%	6,281 $936,000
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $5,432 - $6,760	41 Added 0.66%	6,262 $843,000
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $24,439 - $28,145	169 Added 2.79%	6,221 $991,000
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $27,385 - $32,842	198 Added 3.38%	6,052 $0
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $81,062 - $92,973	604 Added 11.5%	5,854 $786,000
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $11,422 - $14,521	-83 Reduced 1.56%	5,250 $804,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $103,736 - $128,707	-786 Reduced 12.85%	5,333 $864,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $69,936 - $88,490	651 Added 11.91%	6,119 $828,000
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $6,490 - $7,367	61 Added 1.13%	5,468 $590,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $38,506 - $42,898	-366 Reduced 6.34%	5,407 $609,000
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $590,577 - $650,155	5,773 New	5,773 $625,000

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mba Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mba Advisors LLC with notifications on news.

Account